杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/09/18 | 1,960 | 1,967 | 1,933 | 1,935 | -41 | -2.1% | 195,200 |
2015/09/17 | 1,989 | 1,989 | 1,955 | 1,976 | +5 | +0.3% | 172,500 |
2015/09/16 | 2,017 | 2,019 | 1,956 | 1,971 | -29 | -1.5% | 172,900 |
2015/09/15 | 2,027 | 2,036 | 1,990 | 2,000 | -24 | -1.2% | 169,800 |
2015/09/14 | 2,039 | 2,066 | 2,022 | 2,024 | +18 | +0.9% | 149,300 |
2015/09/11 | 1,985 | 2,025 | 1,984 | 2,006 | +2 | +0.1% | 245,100 |
2015/09/10 | 1,978 | 2,024 | 1,968 | 2,004 | -6 | -0.3% | 197,400 |
2015/09/09 | 1,988 | 2,010 | 1,975 | 2,010 | +85 | +4.4% | 276,700 |
2015/09/08 | 1,996 | 1,997 | 1,923 | 1,925 | -72 | -3.6% | 181,000 |
2015/09/07 | 1,998 | 2,022 | 1,967 | 1,997 | -3 | -0.2% | 119,600 |
2015/09/04 | 2,061 | 2,068 | 1,986 | 2,000 | -52 | -2.5% | 142,700 |
2015/09/03 | 2,038 | 2,097 | 2,036 | 2,052 | +27 | +1.3% | 147,400 |
2015/09/02 | 2,028 | 2,066 | 2,005 | 2,025 | -29 | -1.4% | 329,700 |
2015/09/01 | 2,158 | 2,196 | 2,054 | 2,054 | -96 | -4.5% | 259,100 |
2015/08/31 | 2,134 | 2,153 | 2,104 | 2,150 | +23 | +1.1% | 220,500 |
2015/08/28 | 2,118 | 2,128 | 2,092 | 2,127 | +70 | +3.4% | 179,800 |
2015/08/27 | 2,105 | 2,126 | 2,045 | 2,057 | -17 | -0.8% | 265,700 |
2015/08/26 | 2,017 | 2,083 | 2,013 | 2,074 | +70 | +3.5% | 286,800 |
2015/08/25 | 2,029 | 2,108 | 2,004 | 2,004 | -110 | -5.2% | 350,100 |
2015/08/24 | 2,180 | 2,200 | 2,112 | 2,114 | -110 | -4.9% | 189,400 |
2015/08/21 | 2,266 | 2,271 | 2,223 | 2,224 | -82 | -3.6% | 206,500 |
2015/08/20 | 2,327 | 2,366 | 2,306 | 2,306 | -30 | -1.3% | 164,300 |
2015/08/19 | 2,358 | 2,371 | 2,326 | 2,336 | -37 | -1.6% | 175,900 |
2015/08/18 | 2,354 | 2,383 | 2,350 | 2,373 | +15 | +0.6% | 168,000 |
2015/08/17 | 2,386 | 2,404 | 2,353 | 2,358 | -19 | -0.8% | 232,700 |
2015/08/14 | 2,377 | 2,387 | 2,351 | 2,377 | ±0 | ±0% | 165,000 |
2015/08/13 | 2,390 | 2,390 | 2,351 | 2,377 | -21 | -0.9% | 253,300 |
2015/08/12 | 2,445 | 2,449 | 2,391 | 2,398 | -62 | -2.5% | 210,300 |
2015/08/11 | 2,454 | 2,467 | 2,405 | 2,460 | +10 | +0.4% | 234,900 |
2015/08/10 | 2,423 | 2,466 | 2,413 | 2,450 | +31 | +1.3% | 159,500 |
2015/08/07 | 2,450 | 2,461 | 2,415 | 2,419 | -54 | -2.2% | 220,100 |
2015/08/06 | 2,493 | 2,522 | 2,473 | 2,473 | -16 | -0.6% | 179,300 |
2015/08/05 | 2,457 | 2,499 | 2,434 | 2,489 | +43 | +1.8% | 272,300 |
2015/08/04 | 2,457 | 2,490 | 2,407 | 2,446 | -23 | -0.9% | 329,300 |
2015/08/03 | 2,438 | 2,474 | 2,428 | 2,469 | +52 | +2.2% | 176,900 |
2015/07/31 | 2,475 | 2,483 | 2,409 | 2,417 | -57 | -2.3% | 229,800 |
2015/07/30 | 2,519 | 2,540 | 2,430 | 2,474 | -15 | -0.6% | 269,900 |
2015/07/29 | 2,470 | 2,507 | 2,427 | 2,489 | -31 | -1.2% | 428,900 |
2015/07/28 | 2,510 | 2,543 | 2,503 | 2,520 | -40 | -1.6% | 209,300 |
2015/07/27 | 2,452 | 2,597 | 2,447 | 2,560 | +128 | +5.3% | 499,000 |
2015/07/24 | 2,454 | 2,465 | 2,421 | 2,432 | -22 | -0.9% | 127,000 |
2015/07/23 | 2,451 | 2,459 | 2,418 | 2,454 | +23 | +0.9% | 154,000 |
2015/07/22 | 2,464 | 2,464 | 2,417 | 2,431 | -24 | -1% | 155,300 |
2015/07/21 | 2,471 | 2,471 | 2,450 | 2,455 | ±0 | ±0% | 94,100 |
2015/07/17 | 2,466 | 2,481 | 2,450 | 2,455 | +9 | +0.4% | 133,700 |
2015/07/16 | 2,503 | 2,503 | 2,441 | 2,446 | -63 | -2.5% | 360,400 |
2015/07/15 | 2,461 | 2,510 | 2,461 | 2,509 | +56 | +2.3% | 235,400 |
2015/07/14 | 2,465 | 2,500 | 2,433 | 2,453 | +16 | +0.7% | 220,000 |
2015/07/13 | 2,415 | 2,445 | 2,393 | 2,437 | +46 | +1.9% | 90,800 |
2015/07/10 | 2,420 | 2,449 | 2,387 | 2,391 | +21 | +0.9% | 238,700 |
2351~
2400
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム